Macleods Olanzapine 5 mg tablets recalled for elevated impurities
Macleods Pharmaceuticals has recalled Olanzapine Tablets USP 5 mg (lot BOB22321A, expiring 07-31-2027) because testing found organic impurities above acceptable limits. The affected bottles were distributed nationwide. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All MacLeods Pharma recalls
What to do
- Check if you have this medication by looking for lot number BOB22321A on the label.
- Contact your pharmacist or doctor if you have affected bottles — do not stop taking your medication without guidance.
- Your pharmacy can verify whether your supply is affected and provide replacement or alternative medication if needed.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 22,032 30-count bottles
- Illnesses reported
- None reported
- Manufactured in
- Village Theda, Post Office Lodhimajra, Tehsil Baddi, District Solan, India
- Classification
- Class III
- Recall number
- D-0867-2026
In the FDA's words
- Description
- Olanzapine Tablets, USP 5 mg, 30-count bottle, Rx Only, Manufactured For: Macleods Pharma USA, Inc. Princeton, NJ, 08540; Manufactured by: Macleods Pharmaceuticals, Ltd, Baddi, Himachal Pradesh, INDIA, NDC 33342-068-07. Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification. Lot: BOB22321A, Exp 07-31-2027. Distribution: Nationwide in the USA Affected quantity: 22,032 30-count bottles
- Hazard
- Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.